3D bioprinting station
Ended Purchase Order Awarded
- Contract number
- 75N95022P00670
- Awardee
-
Regenhu SA UEI KNM2S6AH4YZ4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $336,302
Award facts
- Opportunity
-
- 3D Bioprinting Station Pre-Solicitation · 75N95022Q00443 · Posted Jun 7, 2022
- Contract value 100% obligated
- $336,301.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Switzerland
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $336,301.88 firm-fixed-price purchase order to Regenhu SA, doing business as Regenhu LTD, to deliver one Regenhu 3D Bioprinting Station model R-GEN 200 or equal. The bioprinting station will support research programs at the agency's 3D Tissue Bioprinting Laboratory involving neuronal circuits, neuromuscular junctions, pain, addiction, and other disease models. Place of performance will be the National Institutes of Health campus in Bethesda, Maryland. There is no set-aside designation for this award under North American Industry Classification System code 334516 for analytical laboratory instrument manufacturing and Federal Supply Class 6515 for medical and surgical instruments. The bioprinting station is to be delivered within 90 days to increase the laboratory's capabilities for producing tissue models in support of the National Institute on Drug Abuse's research mission.
Quick answers
Who was awarded contract 75N95022P00670?
75N95022P00670 was awarded to Regenhu SA by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2022.
How much is contract 75N95022P00670 worth?
The government has obligated $336,302 on 75N95022P00670.
Which agency awarded contract 75N95022P00670?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00670, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00670 competed?
The extent of competition for 75N95022P00670 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award